Short answer
Omada Health, Inc. (OMDA) filed its Q3 2025 10-Q quarterly report on Nov 7, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $68M with net income of −$3M.
Q3 2025 key financials · XBRL
- Revenue
- $68M
- −41.5% QoQ
- Net income
- −$3M
- +78.5% QoQ
- Operating margin
- -3.7%
- Gross margin
- 66.3%
- EPS (diluted)
- $0.37
- +137.8% QoQ
Source: XBRL data from the Omada Health, Inc. (OMDA) Q3 2025 10-Q on SEC EDGAR. USD.
Omada Health, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $68.0M, up 49% YoY from $45.5M
- Net loss $3.2M vs $9.2M YoY
- Cardiometabolic programs priced higher than Prevention & Weight Health
- Total members 831,000 vs 543,000 YoY
- Top five health-plan and PBM partners represented 76% of revenue vs 70% YoY
Risk Factors
- Newly triggered IPO-related risk: material weaknesses in internal control could impair timely or accurate reporting and reduce investor confidence
- Most materially updated growth risk: rapid expansion strains management, Care Teams, technology infrastructure, and internal controls
- Regulatory and compliance exposure: healthcare-law violations could trigger civil or criminal penalties, fines, disgorgement, or government-program exclusion
- Near-term market risk: intensified competition may force price declines, reducing sales, profitability, and market share
- Financial risk: net loss $17.9 million for nine months ended September 30, 2025 with accumulated deficit $461.9 million
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Omada Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.